Package Leaflet: Information for the User
Levelina 10 mg/ml cutaneous spray solution
Bifonazol
Read all of this leaflet carefully before you start using this medicine,because it contains important information for you.
Contents of the package leaflet
Bifonazol belongs to a group of medicines called antifungals (imidazole derivatives), which are used to treat skin infections caused by fungi and yeasts.
This medicine is indicated for the treatment of the following superficial skin infections:
Do not use Levelina
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Levelina.
Do not ingest.
For external use only. Avoid contact with eyes or mucous membranes, as it may cause irritation. If accidental contact occurs, rinse with plenty of water.
In case of an allergic reaction during use, treatment should be discontinued and medical attention sought immediately.
It is not recommended to treat the affected area with other skin medicines at the same time.
Children
No data are available.
Using Levelina with other medicines
Tell your doctor or pharmacist if you are using or have recently used other medicines or if you might use any other medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
As a precautionary measure, it is preferable to avoid using this medicine during pregnancy.
It is not known whether bifonazol passes into breast milk; therefore, your doctor will decide whether to interrupt breastfeeding or treatment after considering the benefits of breastfeeding for the child and the benefits of treatment for the mother.
Driving and using machines
Levelina has no or negligible influence on the ability to drive or use machines.
Follow exactly the administration instructions of this medicine as indicated by your doctor. In case of doubt, consult your doctor or pharmacist.
Levelina should be applied once a day, preferably at night before bedtime.
The recommended durationof treatmentis:
Method of use
For cutaneous use.
Wash and dry the infected skin carefully before each application. Apply a few drops of solution to the affected area and spread by rubbing.
If you use more Levelina than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to a medical center immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Levelina
Do not use a double dose to make up for forgotten doses.
If you have forgotten a dose, apply another as soon as possible and continue with the new schedule. If the time of the next application is very close, skip the forgotten dose and apply the next dose.
If you stop using Levelina
Do not stop treatment without consulting your doctor, as the symptoms of your disease may reappear or worsen.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effectshave been reported with a frequency that cannot be estimated (cannot be determined from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Levelina
Appearance and packaging of the product
Transparent and colorless solution.
This medicine is presented in a 30-milliliter spray container with a spray device.
Marketing authorization holder
LABORATORIOS ERN, S.A.
Perú, 228 - 08020 Barcelona, Spain
Manufacturers
Laboratorios ERN, S.A.
Gorcs Lladó, 188.
08210 - Barberá del Vallés
Barcelona
Spain
Date of last revision of this leaflet: November 2013.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of LEVELINA 10 mg/ml CUTANEOUS SPRAY SOLUTION in October, 2025 is around 4.34 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.